Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Długosz‐Danecka, Monika
65  Ergebnisse:
Personensuche X
?
1

Molnupiravir is effective in patients with haematological m..:

Bołkun, Łukasz ; Pula, Bartosz ; Kołkowska‐Leśniak, Agnieszka...
International Journal of Cancer.  153 (2023)  6 - p. 1251-1256 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Ibrutinib does not have clinically relevant interactions wi..:

Jong, Jan ; Mitselos, Anna ; Jurczak, Wojciech...
Pharmacology Research & Perspectives.  8 (2020)  5 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
3

The average relative dose intensity of R‐CHOP is an indepen..:

Długosz‐Danecka, Monika ; Szmit, Sebastian ; Ogórka, Tomasz..
Cancer Medicine.  8 (2019)  3 - p. 1103-1109 , 2019
Link: https://doi.org/10.1002/..
 
?
4

Pixantrone plus rituximab versus gemcitabine plus rituximab..:

Pettengell, Ruth ; Długosz‐Danecka, Monika ; Andorsky, David...
British Journal of Haematology.  188 (2019)  2 - p. 240-248 , 2019
Link: https://doi.org/10.1111/..
 
?
5

Outcomes of treatment with dose‐adjusted EPOCH‐R or R‐CHOP ..:

Malenda, Agata ; Kołkowska‐Leśniak, Agnieszka ; Puła, Bartosz...
European Journal of Haematology.  104 (2019)  1 - p. 59-66 , 2019
Link: https://doi.org/10.1111/..
 
?
6

The Phase 3 Study ECHELON‐1 Evaluating Brentuximab Vedotin ..:

Borchmann, Peter ; Fosså, Alexander ; Długosz‐Danecka, Monika...
HemaSphere.  2 (2018)  3 - p. , 2018
Link: https://doi.org/10.1097/..
 
?
7

Higher Mortality in Patients With Diffuse Large B-cell Lymp..:

Szmit, Sebastian ; Długosz-Danecka, Monika ; Drozd-Sokołowska, Joanna...
Heart, Lung and Circulation.  33 (2024)  5 - p. 675-683 , 2024
Link: https://doi.org/10.1016/..
 
?
8

Early efficacy and safety of obinutuzumab with chemotherapy..:

Paszkiewicz-Kozik, Ewa ; Hus, Iwona ; Palka, Monika...
Advances in Clinical and Experimental Medicine.  32 (2023)  1 - p. 131-136 , 2023
Link: https://doi.org/10.17219..
 
?
9

Final results and overall survival data from a phase II stu..:

Le Gouill, Steven ; Długosz-Danecka, Monika ; Rule, Simon...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
10

Safety of AFM11 in the treatment of patients with B-cell ma..:

Topp, Max ; Dlugosz-Danecka, Monika ; Skotnicki, Aleksander B....
Trials.  24 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
11

The PD-1- and LAG-3-targeting bispecific molecule tebotelim..:

Luke, Jason J. ; Patel, Manish R. ; Blumenschein, George R....
Nature Medicine.  29 (2023)  11 - p. 2814-2824 , 2023
Link: https://doi.org/10.1038/..
 
?
12

Outcome of SARS-CoV-2-Infected Polish Patients with Chronic..:

Puła, Bartosz ; Pruszczyk, Katarzyna ; Pietrusza, Ewa...
Cancers.  14 (2022)  3 - p. 558 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Bing-Neel Syndrome, a Rare Presentation of Waldenström Macr..:

Drozd-Sokołowska, Joanna ; Waszczuk-Gajda, Anna ; Witkowska, Magdalena...
Journal of Clinical Medicine.  11 (2022)  15 - p. 4447 , 2022
Link: https://doi.org/10.3390/..
 
?
14

Older patients (aged ≥60 years) with previously untreated a..:

Evens, Andrew M. ; Connors, Joseph M. ; Younes, Anas...
Haematologica.  107 (2021)  5 - p. 1086-1094 , 2021
Link: https://doi.org/10.3324/..
 
?
15

Tafasitamab for the treatment of relapsed or refractory dif..:

Salles, Gilles ; Długosz-Danecka, Monika ; Ghesquières, Hervé.
Expert Opinion on Biological Therapy.  21 (2021)  4 - p. 455-463 , 2021
Link: https://doi.org/10.1080/..
 
1-15